Skip to content

Clinical trials

Hemorrhage trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Norway Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20093
20111
20131
20141
20152
20162
20171
20181
20192
20212
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Terminated3
Withdrawn2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Haukeland University Hospital3
St. Olavs Hospital3
Helsinki University Central Hospital2
Idorsia Pharmaceuticals Ltd.2
Oslo University Hospital2
Sangart2
AstraZeneca1
Boehringer Ingelheim1
Cellphire Therapeutics, Inc.1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage24
Thrombocytopenia4
Hematologic Diseases3
Wounds and Injuries3
Acidosis, Lactic2
Autoimmune Diseases2
Blood Platelet Disorders2
Hemorrhagic Disorders2
Immune System Diseases2
Peptic Ulcer2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.